IL1B and neoplasm: Notably, single depletion of IL-1β with the neutralization antibody could sufficiently restore the STC in the tumor-bearing mice, further ABX treatment failed to rescue the STC to a higher extend, suggesting that IL-1β is the dominant pro-inflammatory cytokine mediating STC decline in the tumor-bearing mice.